Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Feigenbaum

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 22, 2000
Viral shedding and biodistribution of G207, a multimutated, conditionally replicating herpes simplex virus type 1, after intracerebral inoculation in aotusT Todo, F Feigenbaum, S D Rabkin, et al.
Journal of Virology|July 10, 1999
Attenuated, replication-competent herpes simplex virus type 1 mutant G207: safety evaluation of intracerebral injection in nonhuman primatesW D Hunter, R L Martuza, F Feigenbaum, et al.
Gene Therapy|June 14, 2000
Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trialJ M Markert, M D Medlock, S D Rabkin, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 22, 2000
Viral shedding and biodistribution of G207, a multimutated, conditionally replicating herpes simplex virus type 1, after intracerebral inoculation in aotusT Todo, F Feigenbaum, S D Rabkin, et al.
Journal of Virology|July 10, 1999
Attenuated, replication-competent herpes simplex virus type 1 mutant G207: safety evaluation of intracerebral injection in nonhuman primatesW D Hunter, R L Martuza, F Feigenbaum, et al.
Gene Therapy|June 14, 2000
Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trialJ M Markert, M D Medlock, S D Rabkin, et al.
Pageof 2